Clinical trial
Open Label Clinical Trial With Rituximab (MabThera ®) in Ankylosing Spondylitis
NCT00432653 · Charite University, Berlin, Germany, Other · Unknown status
Key facts
| NCT number | NCT00432653 |
|---|---|
| Title | Open Label Clinical Trial With Rituximab (MabThera ®) in Ankylosing Spondylitis |
| Official title | Open Label Clinical Trial With Rituximab (MabThera ®) in Ankylosing Spondylitis |
| Lead sponsor | Charite University, Berlin, Germany, Other |
| Collaborators | Hoffmann-La Roche Industry |
| Status | Unknown status |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Ankylosing Spondylitis |
| Intervention type | Drug |
| Interventions | rituximab |
| Enrollment | 20 |
| Start date | Mar 1, 2007 |
| Completion | Nov 1, 2009 |
| First posted | Feb 8, 2007 |
| Last update posted | Feb 8, 2007 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: